Data Science | Boehringer Ingelheim

At Boehringer Ingelheim, we are investing into the power of data science with a clear purpose: to revolutionize our research and development, accelerating the journey from scientific discoveries to breakthrough therapies. By seamlessly integrating state-of-the-art technologies into every stage of the process – from target identification to clinical trials – we unlock invaluable insights that guide our drug discovery and development, enhancing the probability of success and enabling us to address unmet patient needs more swiftly.

“Our goal is to harness the power of data science to transform drug discovery and development. We want to catalyze the next breakthrough therapies that change lives by accelerating timelines, improving scientific and clinical success and further elevating patient centricity.”

Jan Jensen, Global Head of Computational Biology and Digital Sciences at Boehringer Ingelheim

Using data in pharmaceutical research to better address patient needs

In the world of pharmaceutical research and development, data science plays a pivotal role in transforming the way we address patient needs. With vast amounts of data at our disposal, including clinical trials, biobank data, and electronic health records, we have an unprecedented opportunity to gain profound insights into the origins of diseases and explore potential treatments and cures.

However, the challenge lies in unraveling the intricate interplay between biological processes and the manifestation of diseases in patients. Mere targeting of biological pathways does not guarantee significant improvement in clinical symptoms. To overcome this hurdle, our pharmaceutical R&D efforts intersect with powerful data science tools, enabling us to leverage data to forecast the intricate connections between biological mechanisms and symptoms. This accelerates the path towards bringing groundbreaking therapies to patients who need them the most.

Our team of dedicated experts in data science and health informatics possess the skills to develop advanced data analytics tools and generate scientific insights to advance novel target discoveries, create new biomarker insights, and optimize drug modality design across all Therapeutic Areas in Boehringer Ingelheim. Moreover, they excel in developing intricate machine learning models and simulations of molecular, cellular, and organismic systems. By harnessing these cutting-edge technologies, we increase the probability of achieving clinical success through precision medicine and other innovative approaches.

With our unwavering commitment to harnessing the power of data, we strive to revolutionize pharmaceutical research, create patient-centric solutions, and ultimately transform the lives of those affected by diseases.